Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 58, Status: Authorised

Submitted by Anonymous (not verified) on 14 October 2025 - 12:34

Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 58, Status: Authorised

Human medicines European public assessment report (EPAR): Evusheld, tixagevimab,cilgavimab, Date of authorisation: 25/03/2022, Revision: 10, Status: Withdrawn

Submitted by Anonymous (not verified) on 14 October 2025 - 12:00

Human medicines European public assessment report (EPAR): Evusheld, tixagevimab,cilgavimab, Date of authorisation: 25/03/2022, Revision: 10, Status: Withdrawn

EMA/HMA annual data forum, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 9 December 2025, 09:00 (CET) to 9 December 2025, 17:30 (CET)

Submitted by Anonymous (not verified) on 14 October 2025 - 10:33

EMA/HMA annual data forum, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 9 December 2025, 09:00 (CET) to 9 December 2025, 17:30 (CET)

Refresher training webinar on post-authorisation procedure management in IRIS for marketing authorisation holders, Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 September 2025, 10:00 (CEST) to 30 September 2025, 12:00 (CEST)

Submitted by Anonymous (not verified) on 14 October 2025 - 10:16

Refresher training webinar on post-authorisation procedure management in IRIS for marketing authorisation holders, Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 September 2025, 10:00 (CEST) to 30 September 2025, 12:00 (CEST)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness